These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Amiodarone and secondary prevention. The EMIAT study]. Munoz A Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():67-9. PubMed ID: 1726998 [TBL] [Abstract][Full Text] [Related]
24. Can antiarrhythmic drugs survive survival trials? Pratt CM; Waldo AL; Camm AJ Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220 [TBL] [Abstract][Full Text] [Related]
25. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Lazzara R Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326 [TBL] [Abstract][Full Text] [Related]
26. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction]. Funck-Brentano C Rev Prat; 1992 Nov; 42(17):2175-8. PubMed ID: 1290040 [TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Pfisterer M; Kiowski W; Burckhardt D; Follath F; Burkart F Am J Cardiol; 1992 Jun; 69(17):1399-402. PubMed ID: 1590226 [TBL] [Abstract][Full Text] [Related]
28. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890 [TBL] [Abstract][Full Text] [Related]